Martin Babler - Insider Trading & Ownership

Entity
Individual
Location
C/O Alumis Inc., 280 East Grand Avenue, South San Francisco, California
All Insider Reports
All Insider Reports

Ownership of Martin Babler

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ETNB 89bio, Inc. Director May 2, 2024
ALMS ALUMIS INC. President, CEO and Chairman, Director Jun 27, 2024
NLTX Neurogene Inc. Director Jun 8, 2023
PRLD Prelude Therapeutics Inc Director Jun 14, 2024

Insider Transactions Reported by Martin Babler:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership